Repurposed Drugs & Integrative Cancer Care (2026)
An evidence‑aware guide to off‑label cancer therapies, integrative oncology, and emerging research — without hype or false promises. This page serves as the central hub for OneDayMD’s coverage of repurposed drugs in cancer care, integrating conventional oncology standards with systems biology, real‑world data, and ethical analysis. What This Hub Covers (Quick Overview) This hub explains: What repurposed drugs are — and what they are not. Which drugs show credible anti‑cancer signals vs speculation. How repurposed therapies may (or may not) integrate with standard oncology. The evidence hierarchy used across OneDayMD. Safety, ethics, and regulatory realities. It is designed for patients, clinicians, and researchers seeking clarity rather than promotion . Diverse cancer hallmarks targeted by repurposed non-oncology drugs. This figure was created with Biorender.com. Source: Nature 2024 Executive Summary Repurposed drugs in cancer care refer to existing, FDA‑approved medications or...